comparemela.com

Latest Breaking News On - Tonix pharmaceuticals company profile - Page 1 : comparemela.com

StockNews.com Initiates Coverage on Tonix Pharmaceuticals (NASDAQ:TNXP)

Equities researchers at StockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) in a report issued on Wednesday. The brokerage set a “sell” rating on the stock. Separately, Dawson James began coverage on shares of Tonix Pharmaceuticals in a report on Wednesday, February 28th. They set a “buy” rating and a […]

Zembrace-symtouch
Dawson-james
Tonix-pharmaceuticals-company-profile
News-ratings-for-tonix-pharmaceuticals-daily
Armistice-capital
Hedge-funds-weigh-in-on-tonix-pharmaceuticals
Sabby-management
Tonix-pharmaceuticals
Tonix-pharmaceuticals-holding-corp
Tonix-pharmaceuticals-price-performance
Acadian-asset-management
Get-free-report

Tonix Pharmaceuticals (NASDAQ:TNXP) Coverage Initiated at StockNews.com

Tonix Pharmaceuticals (NASDAQ:TNXP) Coverage Initiated at StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Dawson-james
Zembrace-symtouch
Tonix-pharmaceuticals-trading-down
Tonix-pharmaceuticals-holding-corp
Millennium-management
Raymond-james-associates
News-ratings-for-tonix-pharmaceuticals-daily
Tonix-pharmaceuticals
Tonix-pharmaceuticals-company-profile
Virtu-financial
Get-free-report
Pharmaceuticals-trading-down

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Sees Significant Increase in Short Interest

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) saw a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 967,000 shares, a growth of 56.9% from the February 29th total of 616,200 shares. Approximately 1.2% of the shares of the company are short sold. […]

Zembrace-symtouch
Dawson-james
Renaissance-technologies
Geode-capital-management
Tonix-pharmaceuticals-holding-corp
Tonix-pharmaceuticals-trading-down
Virtu-financial
Nasdaq
News-ratings-for-tonix-pharmaceuticals-daily
Tonix-pharmaceuticals
Hedge-funds-weigh-in-on-tonix-pharmaceuticals
Tonix-pharmaceuticals-company-profile

Tonix Pharmaceuticals (NASDAQ:TNXP) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research note released on Tuesday. The brokerage issued a sell rating on the stock. Separately, Dawson James started coverage on Tonix Pharmaceuticals in a report on Wednesday, February 28th. They set a buy rating and a $3.00 price target for the […]

Dawson-james
Zembrace-symtouch
Tonix-pharmaceuticals-holding-corp
Sabby-management
Geode-capital-management
Institutional-investors-weigh-in-on-tonix-pharmaceuticals
Tonix-pharmaceuticals-stock-down
Tonix-pharmaceuticals
Jpmorgan-chase-co
Tonix-pharmaceuticals-company-profile
News-ratings-for-tonix-pharmaceuticals-daily
Armistice-capital

Tonix Pharmaceuticals (NASDAQ:TNXP) Receives New Coverage from Analysts at StockNews.com

Research analysts at StockNews.com initiated coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) in a research report issued on Tuesday. The brokerage set a “sell” rating on the stock. Separately, Dawson James initiated coverage on shares of Tonix Pharmaceuticals in a research report on Wednesday, February 28th. They issued a “buy” rating […]

Zembrace-symtouch
Dawson-james
Northern-trust-corp
Tonix-pharmaceuticals-company-profile
Institutional-trading-of-tonix-pharmaceuticals
Tonix-pharmaceuticals
News-ratings-for-tonix-pharmaceuticals-daily
Jpmorgan-chase-co
Tonix-pharmaceuticals-stock-down
Tonix-pharmaceuticals-holding-corp
York-mellon-corp
Charles-schwab-investment-management-inc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.